Serotonin 5-HT3 receptor antagonist. Prepn: J. Berger et al., EP 430190; eidem, US 5202333 (1991, 1993 both to Syntex); R. D. Clark et al., J. Med. Chem. 36, 2645 (1993). Improved synthesis: B. A. Kowalczyk, Heterocycles 43, 1439 (1996). Receptor binding study: E. H. F. Wong et al., Br. J. Pharmacol. 114, 851 (1995). Pharmacology: R. M. Eglen et al., ibid. 860. Clinical efficacy and pharmacokinetics: P. Eisenberg et al., Ann. Oncol. 15, 330 (2004). Clinical trial in prevention of chemotherapy-induced nausea and vomiting: R. Gralla et al., Ann. Oncol. 14, 1570 (2003). Review of pharmacology and clinical experience: S. M. Grunberg, J. M. Koeller, Expert Opin. Pharmacother. 4, 2297-2303 (2003); M. A. A. Siddiqui, L. J. Scott, Drugs 64, 1125-1132 (2004).
Antiemetic.
Serotonin Receptor Antagonist; Antiemetic